Things are looking up for these drug companies as they make progress with the FDA

Even if biotech companies like TG Therapeutics and Clovis Oncology don’t get bought out, they’re still attractive on a standalone basis.

Cramer got his first vaccine shot, and he's enthusiastic about the innovative technology and science that will fuel economic and human recovery.

Silver Spike Acquisition, Immutep, 8x8, TG Therapeutics and TechTarget are five of the top stock gainers on Thursday.

TG Therapeutics soars after the biopharma reports positive test results for its multiple sclerosis treatment.

Some stocks that will work under a Trump administration also will work in a Biden portfolio, says Jim Cramer. He looks at which sectors and industries are poised to profit -- and which aren't.

As we leap into earnings season, Jim Cramer look at profits, trade, employment, inflation and whether this rally is worth the risk. Here's your game plan for next week.

Jim Cramer says we need to bake in as much bad news as possible before the market really finds a bottom. There will be more declines ahead.

It's the right amount of growth and wage gains, says Jim Cramer. And here's your game plan for next week.

The 14-week decline in gasoline prices ended while two million people in Florida are still without power.

A new EV would radically change how cars are made and that could be a threat to the market leader.

The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.